Chapel Hill, NC, United States of America

Allen D Roses

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Zinfandel Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allen D Roses. Retrieved from https://idiyas.com/inventor/allen-d-roses

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 25.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 1.2

ph-index = 4

Forward Citations = 22(Granted Patents)

Company Filing History:

8 out of 8

Zinfandel Pharmaceuticals, Inc.

patents

2 out of 1,228

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11179375 - Methods and drug products for treating Alzheimer's disease (2021-11-23),

2. 11021751 - Disease risk factors and methods of use (2021-06-01),

3. 11001893 - Methods for detecting structural variants in neurodegenerative disease (2021-05-11),

4. 10865449 - Method of identifying disease risk factors (2020-12-15),

5. 9724339 - Methods and drug products for treating alzheimer's disease (2017-08-08),

6. 9102666 - Methods and drug products for treating Alzheimer's disease (2015-08-11),

7. 8846315 - Disease risk factors and methods of use (2014-09-30),

8. 8815508 - Method of identifying disease risk factors (2014-08-26),

Title: The Innovative Contributions of Allen D. Roses

Introduction

Allen D. Roses is a prominent inventor based in Chapel Hill, NC, known for his significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. With a total of eight patents to his name, Roses has made remarkable strides in developing methods and drug products aimed at improving cognitive health.

Latest Patents

Roses' latest patents focus on innovative approaches to treating Alzheimer's disease. One notable patent involves drug products containing low-dose pioglitazone, which are designed to delay the onset of cognitive impairment associated with Alzheimer's. This patent outlines methods of manufacture and treatment protocols that include assessing a subject's risk of developing Alzheimer's based on age and genetic factors, specifically the TOMM40 523 genotype. Another patent addresses genetic variants linked to the development of Alzheimer's, providing methods for treatment with active agents upon detecting specific genetic markers.

Career Highlights

Throughout his career, Allen D. Roses has worked with notable companies in the pharmaceutical industry, including Zinfandel Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited. His work has been instrumental in advancing research and development in Alzheimer's treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Roses has collaborated with various professionals in the field, including his coworker Rajneesh Taneja. These partnerships have contributed to the success of his research and the development of innovative treatment methods.

Conclusion

Allen D. Roses stands out as a key figure in the fight against Alzheimer's disease, with his innovative patents and collaborative efforts paving the way for future advancements in treatment. His work continues to inspire and influence the medical community.

Profile summary based on public USPTO records.